Table 5.
Logistic regression analysis of thin-cap fibroatheroma
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age, years | 1.02 (0.99–1.05) | 0.119 | ||
| Men | 1.62 (0.74–3.53) | 0.227 | ||
| BMI, kg/m2 | 0.95 (0.87–1.03) | 0.207 | ||
| Diabetes group | ||||
| Short vs. Non | 1.87 (0.98–3.55) | 0.056 | 1.78 (0.93–3.40) | 0.082 |
| Long vs. Non | 2.97 (1.33–6.61) | 0.008* | 3.06 (1.36–6.88) | 0.007* |
| Hypertension | 0.66 (0.38–1.14) | 0.136 | ||
| Smoking | 1.33 (0.72–2.45) | 0.363 | ||
| TC, mg/dL | 1.01 (1.00–1.01) | 0.072 | ||
| TG, mg/dL | 1.00 (1.00–1.00) | 0.123 | ||
| LDL-C, mg/dL | 1.01 (1.00–1.02) | 0.043* | 1.01 (1.00–1.02) | 0.048* |
| HDL-C, mg/dL | 0.99 (0.97–1.02) | 0.736 | ||
| Hs-CRP, mg/L | 0.96 (0.91–1.02) | 0.261 | ||
| eGFR, mL/min/1.73 m2 | 0.99 (0.98–1.00) | 0.063 | ||
| Prior statin use | 0.58 (0.26–1.30) | 0.183 | ||
BMI body mass index, CI, confidence interval, HDL-C high-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, Hs-CRP high-sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, Long-DM patients with a long duration of diabetes, Non-DM patients without diabetes, OR, odds ratio, Short-DM patients with a short duration of diabetes, TC total cholesterol, TG triglyceride
* P < 0.05